Screener / SEC EDGAR /CIK 0001815442 /10-K filed Feb 26, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

Kymera Therapeutics, Inc. KYMR

Compare with peers Embed
Planned sales, announced before they happen

6 trading plans running, 67 Form 144 notices for $489.7M

10-Q, 10-K and Form 144
Plans running now 6 Nello Mainolfi, Bruce Jacobs, Elena Ridloff, Jeremy Chadwick, Noah Goodman, Jared Gollob
Plans adopted 13 reported since May 4, 2023 Form 144 notices 67 $489.7M the sellers expected to sell

What KYMR's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Sep 20, 2024 to Dec 31, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired. The ten newest plans are drawn; all are in the table.

InsiderWhatDateReported in
Nello Mainolfi
Founder, President, Chief Executive Officer
Adopted 10b5-1 plan Mar 24, 2026 10-Q Apr 30, 2026
Bruce Jacobs
Chief Financial Officer
Adopted 10b5-1 plan Mar 23, 2026 10-Q Apr 30, 2026
Bruce Booth
Director
Adopted 10b5-1 plan Dec 16, 2025 10-K Feb 26, 2026
Elena Ridloff
Director
Adopted 10b5-1 plan Dec 11, 2025 10-K Feb 26, 2026
Jeremy Chadwick
Chief Operating Officer
Adopted 10b5-1 plan Dec 10, 2025 10-K Feb 26, 2026
Noah Goodman
Chief Business Officer
Adopted 10b5-1 plan Dec 10, 2025 10-K Feb 26, 2026
Pamela Esposito
Director
Adopted 10b5-1 plan Sep 17, 2025 10-Q Nov 4, 2025
Jared Gollob
Chief Medical Officer
Adopted 10b5-1 plan Jun 2, 2025 10-Q Aug 11, 2025
Elena Ridloff
Director
Adopted 10b5-1 plan Nov 25, 2024 10-K Feb 27, 2025
Jeffrey Albers
Director
Adopted 10b5-1 plan Sep 20, 2024 10-Q Oct 31, 2024
Bruce Jacobs
Chief Financial Officer
Adopted 10b5-1 plan Sep 6, 2024 10-Q Oct 31, 2024
Nello Mainolfi
Founder, President, Chief Executive Officer
Adopted 10b5-1 plan Sep 6, 2024 10-Q Oct 31, 2024
Pamela Esposito
Director
Adopted 10b5-1 plan Jun 18, 2024 10-Q Aug 7, 2024
Bruce Jacobs
Chief Financial Officer
Ended 10b5-1 plan Dec 22, 2023 10-K Feb 22, 2024
Nello Mainolfi
Founder, President, Chief Executive Officer
Ended 10b5-1 plan Dec 20, 2023 10-K Feb 22, 2024
Show the other 7 plans

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 4, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Oct 1, 2026 Mainolfi Nello
Officer, Director
30,000 $3.4M
Sep 4, 2026 Brian Adams
Officer
6,371 $747K
Sep 2, 2026 JEREMY CHADWICK
Officer
10,879 $1.3M
Jul 7, 2026 Mainolfi Nello
Officer, Director
50,000 $6.0M
Jul 2, 2026 Mainolfi Nello
Officer, Director
80,000 $9.1M
Jul 1, 2026 NOAH GOODMAN
Officer
3,389 $389K
Jun 30, 2026 BRUCE N. JACOBS
Officer
77,109 $8.4M
Jun 29, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
10,473 $1.1M
Jun 29, 2026 Atlas Venture Fund X, LP
Shareholder
66,177 $7.2M
Jun 26, 2026 Atlas Venture Fund X, LP
Shareholder
410,427 $47.8M
Jun 26, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
57,451 $6.7M
Jun 26, 2026 BVF PARTNERS L P/IL
Affiliate of Director
1,630,658 $189.9M
Jun 25, 2026 NOAH GOODMAN
Officer
5,000 $499K
Jun 25, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
67,329 $6.7M
Jun 25, 2026 Atlas Venture Fund X, LP
Shareholder
480,992 $48.0M
Jun 24, 2026 Atlas Venture Fund X, LP
Shareholder
118,178 $11.6M
Jun 24, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
16,542 $1.6M
Jun 23, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
173 $17K
Jun 23, 2026 Atlas Venture Fund X, LP
Shareholder
1,235 $123K
Jun 22, 2026 NOAH GOODMAN
Officer
2,500 $226K
Jun 22, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
34,152 $3.1M
Jun 22, 2026 Atlas Venture Fund X, LP
Shareholder
243,976 $22.1M
Jun 18, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
14,128 $1.3M
Jun 18, 2026 Atlas Venture Fund X, LP
Shareholder
100,928 $9.1M
Jun 17, 2026 JEREMY CHADWICK
Officer
66,893 $5.8M
Jun 17, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
12,902 $1.1M
Jun 17, 2026 Atlas Venture Fund X, LP
Shareholder
92,169 $8.1M
Jun 17, 2026 Bruce Booth
Director
11,741 $1.0M
May 26, 2026 JEREMY CHADWICK
Officer
13,130 $1.0M
May 26, 2026 Chadwick Jeremy G
Officer
4,054 $318K
May 11, 2026 ELENA RIDLOFF
Director
3,000 $258K
Apr 29, 2026 Mainolfi Nello
Officer, Director
30,000 $2.5M
Apr 22, 2026 JEREMY CHADWICK
Officer
300 $26K
Apr 22, 2026 Atlas Venture Fund X, LP
Shareholder
88 $8K
Apr 22, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
12 $1K
Apr 15, 2026 JEREMY CHADWICK
Officer
1,300 $117K
Apr 15, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
385 $35K
Apr 15, 2026 Atlas Venture Fund X, LP
Shareholder
2,750 $247K
Apr 14, 2026 JEREMY CHADWICK
Officer
5,251 $465K
Apr 14, 2026 Bruce Booth
Director
24,000 $2.1M
Apr 9, 2026 Noah Goodman
Officer
11,611 $1.0M
Apr 1, 2026 ELENA RIDLOFF
Director
4,600 $383K
Apr 1, 2026 JEREMY CHADWICK
Officer
14,640 $1.2M
Mar 31, 2026 JEREMY CHADWICK
Officer
7,600 $604K
Mar 31, 2026 ELENA RIDLOFF
Director
7,400 $588K
Mar 23, 2026 JEREMY CHADWICK
Officer
115,977 $9.0M
Mar 20, 2026 PAMELA ESPOSITO
Director
2,500 $199K
Mar 11, 2026 JEREMY CHADWICK
Officer
25,758 $2.2M
Mar 2, 2026 Atlas Venture Opportunity Fund I, LP
Shareholder
25,000 $2.3M
Mar 2, 2026 Atlas Venture Fund X, LP
Shareholder
200,000 $18.3M
Mar 2, 2026 Gollob Jared
Officer
10,613 $956K
Mar 2, 2026 Chadwick Jeremy G
Officer
6,206 $559K
Mar 2, 2026 Jacobs Bruce N.
Officer
12,576 $1.1M
Feb 25, 2026 Mainolfi Nello
Officer, Director
30,000 $2.7M
Feb 20, 2026 PAMELA ESPOSITO
Director
2,500 $216K
Jan 20, 2026 PAMELA ESPOSITO
Director
5,500 $382K
Dec 31, 2025 Mainolfi Nello
Officer, Director
30,000 $2.3M
Dec 17, 2025 PAMELA ESPOSITO
Director
27,563 $2.3M
Dec 12, 2025 Atlas Venture Opportunity Fund I, L.P.
Director
108 $10K
Dec 12, 2025 Atlas Venture Fund X, L.P.
Director
570 $51K
Dec 11, 2025 Atlas Venture Opportunity Fund I, L.P.
Director
976 $86K
Dec 11, 2025 Atlas Venture Fund X, L.P.
Director
5,125 $450K
Dec 10, 2025 Atlas Venture Opportunity Fund I, L.P.
Director
36,769 $3.3M
Dec 10, 2025 Atlas Venture Fund X, L.P.
Director
193,040 $17.4M
Dec 8, 2025 Mainolfi Nello
Officer, Director
100,000 $8.9M
Dec 8, 2025 Jared Gollob
Officer
49,307 $3.3M
Dec 8, 2025 JEFFREY ALBERS
Director
5,000 $333K
Show the other 59 notices

From the Form 144 XML filed with the SEC, since Dec 8, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/KYMR/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.